Pepticore
Antibacterial and Antifungal Drug Development
Startup Pre-Funding Health Tech & Life Sciences Est. 2024
Total Raised
Undisclosed
Pre-Funding
Last Round
Undisclosed
Team
5
1-10 employees
Confidence
78/100
About
PeptiCore is focusing on development of break-through innovations of anti-bacterial drugs. The first product PheLiz, is an antibiotic, active against a wide range of bacterial and fungal species, with a unique structure making it efficacious on antibiotic-resistant microbial strains and exhibiting an unprecedented resilience to microbial resistance. The company is a subsidary of Tarom Innovative Technologies.
Classification
Sector
Health Tech & Life SciencesPharma & Medical Biotechnology
Core Technology
Biologicals
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business Model
B2B
Tags
bioconvergencemicrobiologyantibioticspharmaceuticals
Details
Product Stage
Clinical Trial
Employees
1-10
Exact Count
6
District
Center District
Founded
2024
Registrar
516939790
Locations
Petah Tikva, Israel
Links
Admin
Last Update
Jun 13, 2024
Verified by
Matan Eblagon
Missing
sector, video or image, funding rounds, news, markets, external profiles, not claimed
Team (5)
Dror Melamed
Co-CEO
Ronen Sarousi
Co-CEO
Eran Toledo
CTO
Tzur Bi-Cori
VP Business Development
Prof. Zvi Hayouka
Principal Investigator
Internal
Created by
Maor Perlov (maor.perlov@sncentral.org)
Created
2024-05-07T00:00:00.000Z
Last editor
Matan Eblagon (matane@sncentral.org)